Concert Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering
Published: Feb 19, 2014
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the closing of its initial public offering of 6,000,000 shares of its common stock at a public offering price of $14.00 per share, before underwriting discounts.
Help employers find you! Check out all the jobs and post your resume.